CTO
Dr. Edward Pichinuk is a seasoned R&D executive with over a decade of experience driving innovation at the intersection of biotechnology, AI, and healthcare. With a career spanning from early-stage drug discovery to IND-enabling studies, he specializes in building scalable research platforms that accelerate the path from concept to cure. Dr. Pichinuk has held leadership roles at Pharmaseed, KulaOmics, and DeepCure, where he successfully bridged the gap between computational predictions and biological reality. He holds a Ph.D. in Biology and Immunology from Tel Aviv University and is currently an MBA candidate, combining deep scientific rigor with strategic business acumen.
